Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Mind-body program (DNRS) for Long COVID and ME/CFS

Official title: Mind-Body in Long COVID and Myalgic Encephalomyelitis Study (MILES): A Patient-Centred RCT

Run by University of Alberta · NCT06933173 · Data updated 2026-11-12

We will try the Dynamic Neural Retraining System (DNRS), a mind-body program, in adults with ME/CFS, including those who also have Long COVID.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations2 sites (Calgary, Alberta and 1 other locations)
StatusRecruiting
StartedJuly 10, 2025
Main results expectedDecember 31, 2027
Study endsMarch 2028
Registry record updatedSeptember 9, 2026
Trial IDNCT06933173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who have had ME/CFS for more than six months per the 2015 IOM criteria, can communicate in English, have reliable internet, and are well enough to participate are ideal candidates.

Probably not a fit

People who are too ill to take part, those with a history of inflammatory bowel disease, recent systemic or oral antibiotics, lack reliable internet or English proficiency, or who are currently in other mind-body programs or concurrent studies may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial tests the Dynamic Neural Retraining System (DNRS), a structured mind-body program, in adults with ME/CFS with or without Long COVID. Participants who meet the 2015 IOM criteria for ME/CFS are enrolled at three Canadian sites and must have reliable internet access and English proficiency. Participants are randomized to receive the DNRS intervention or a control condition, with outcomes focused on symptom severity, mood, quality of life, and functional status over the study period. The protocol excludes people who are too ill to participate, have certain medical conditions or recent systemic antibiotics, or who are concurrently receiving other mind-body therapies.

Why it matters

Potential benefit: If successful, the DNRS program could reduce symptom burden and improve quality of life and coping for people with ME/CFS and Long COVID.

How similar studies have gone: Mind-body interventions have shown mixed but sometimes modest benefits for fatigue and quality of life in related conditions, while rigorous trial evidence specifically for DNRS is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older;
* Individuals diagnosed with ME/CFS, according to the Institute of Medicine (2015) criteria, for more than six months.

Exclusion Criteria:

Individuals who: 1) are too ill to participate; 2) lack reliable internet; 3) cannot communicate in English; 4) Presently have or ever had inflammatory bowel disease; and/or 5) Have been prescribed or used an oral or systemic (infusion) antibiotic in the past one month-;; 6) are participating in a concurrent study; 7) are participating in a concurrent mind-body intervention during the study period including

* Art Therapy
* Autogenic training
* Biofeedback/neurofeedback
* Breathing exercise
* Cognitive restructuring
* Dynamic Neural Retraining System
* Emotional Freedom Techniques (EFT)
* Eye movement desensitization and reprocessing (EMDR)
* Guided imagery
* Hypnotherapy/self-hypnosis
* Meditation (mindfulness, mantra, guided, transcendental)
* Mindfulness-based cognitive therapy (MBCT)
* Mindfulness-based Stress Reduction (MBSR)
* Music therapy
* Neurolinguistic programming
* Psychological flexibility
* Qigong
* Relaxation therapy (relaxation response, progressive muscle relaxation)
* Tai Chi
* Visualization
* Yoga and/or starting any other new treatment during the study period, including any mind-body therapy, psychotherapy, prescription medication, over-the-counter medication, etc; 8) have any active medical condition (untreated/uncontrolled) that may explain the presence of fatigue including:
* untreated hypothyroidism (including Hashimoto's disease)
* hyperthyroidism
* diabetes mellitus
* iron deficiency anemia
* other treatable anemia
* iron overload syndrome
* adrenal insufficiency
* Cushing's syndrome
* anorexia nervosa
* iatrogenic conditions such as side effects or interactions of medication(s) or supplements

  • Rheumatological disorders:
* rheumatoid arthritis
* lupus
* polymyositis
* polymyalgia rheumatica
* Sjogren's Syndrome
* Ehlers Danlos Syndromes \[Hypermobility type\]

  • Other heritable disorders of connective tissue:
* Marfan syndrome
* Stickler syndrome etc.

  * Multiple sclerosis
  * Celiac disease
* Note: Patients with celiac disease can present without gastrointestinal symptoms

  • Immune disorders
* such as HIV/AIDS

  • Sleep disorders
* including obstructive sleep apnea

  • Prior illnesses may relapse or may not have completely resolved during treatment.
* Examples are certain malignancies
* leukemia
* infectious diseases such as tuberculosis and chronic hepatitis

  • Active primary psychiatric disorders
* eating disorders
* alcohol
* substance use disorder

Where it's running

  • Peter Lougheed Hospital
    Calgary, Alberta, Canada
    Recruiting
  • University of Alberta Hospital/Kaye Edmonton Clinic
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Sunita Vohra, MD MSc FRCPC FCAHS — University of Alberta
  • Study coordinator: MILES RCT team
  • Email: rctmiles@ualberta.ca
  • Phone: 780-680-8907

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.